The Evidence Base
@theevidencebase.bsky.social
Providing the latest news, opinion and insight into hot topics including real-world data, health economics and outcomes research and patient-centric care.
Overcoming barriers to cell and gene therapy adoption with #realworldevidence | @thermofishersci.bsky.social becarispublishing.com/digital-cont...
Overcoming barriers to cell and gene therapy adoption with real-world evidence | Becaris Publishing
becarispublishing.com
December 11, 2025 at 9:43 AM
Overcoming barriers to cell and gene therapy adoption with #realworldevidence | @thermofishersci.bsky.social becarispublishing.com/digital-cont...
Hot off the press: Our pick of articles within #HTA and #RWE published in November 2025 | Becaris Publishing becarispublishing.com/digital-cont...
Hot off the press: Our pick of articles within HTA and RWE published in November 2025 | Becaris Publishing
becarispublishing.com
December 10, 2025 at 2:37 PM
Hot off the press: Our pick of articles within #HTA and #RWE published in November 2025 | Becaris Publishing becarispublishing.com/digital-cont...
Reposted by The Evidence Base
📢New article alert
New Research Article on “Health outcomes and costs in patients prescribed anticholinergic medications for overactive bladder”.
🔗Read here: becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #OAB #PatientSafety #HEOR
New Research Article on “Health outcomes and costs in patients prescribed anticholinergic medications for overactive bladder”.
🔗Read here: becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #OAB #PatientSafety #HEOR
Becaris Publishing
becarispublishing.com
December 10, 2025 at 10:45 AM
📢New article alert
New Research Article on “Health outcomes and costs in patients prescribed anticholinergic medications for overactive bladder”.
🔗Read here: becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #OAB #PatientSafety #HEOR
New Research Article on “Health outcomes and costs in patients prescribed anticholinergic medications for overactive bladder”.
🔗Read here: becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #OAB #PatientSafety #HEOR
#Quantum technologies in #medicine: Canada–UK leaders explore adoption pathways, #biomedical applications, and opportunities for #GlobalCollaboration | Becaris Publishing becarispublishing.com/digital-cont...
Quantum technologies in medicine: Canada–UK leaders explore adoption pathways, biomedical applications, and opportunities for global collaboration | Becaris Publishing
becarispublishing.com
December 10, 2025 at 10:42 AM
#Quantum technologies in #medicine: Canada–UK leaders explore adoption pathways, #biomedical applications, and opportunities for #GlobalCollaboration | Becaris Publishing becarispublishing.com/digital-cont...
Lessons from a pilot study on #AI coding and analysis of qualitative patient data | @thermofishersci.bsky.social #ISPOREurope becarispublishing.com/digital-cont...
Lessons from a pilot study on AI coding and analysis of qualitative patient data | Becaris Publishing
becarispublishing.com
December 10, 2025 at 9:47 AM
Lessons from a pilot study on #AI coding and analysis of qualitative patient data | @thermofishersci.bsky.social #ISPOREurope becarispublishing.com/digital-cont...
Rethinking global pricing strategies through the most-favored nation lens | becarispublishing.com/digital-cont...
Rethinking global pricing strategies through the most-favored nation lens | Becaris Publishing
becarispublishing.com
December 9, 2025 at 12:23 PM
Rethinking global pricing strategies through the most-favored nation lens | becarispublishing.com/digital-cont...
Reposted by The Evidence Base
📢New article alert
New Research Article on “Evaluating amyloid-beta as a surrogate endpoint in trials of anti-amyloid-beta drugs in Alzheimer’s disease: a Bayesian meta-analysis”.
🔗 becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #AlzheimersDisease #MetaAnalysis #SurrogateEndpoints
New Research Article on “Evaluating amyloid-beta as a surrogate endpoint in trials of anti-amyloid-beta drugs in Alzheimer’s disease: a Bayesian meta-analysis”.
🔗 becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #AlzheimersDisease #MetaAnalysis #SurrogateEndpoints
Evaluating amyloid-beta as a surrogate endpoint in trials of anti-amyloid-beta drugs in Alzheimer’s disease: a Bayesian meta-analysis
Aim: The use of amyloid-beta (Aβ) clearance to support regulatory approvals of drugs in
Alzheimer’s disease (AD) remains controversial. We evaluate Aβ as a potential trial-level
surrogate endpoint for...
becarispublishing.com
December 9, 2025 at 10:34 AM
📢New article alert
New Research Article on “Evaluating amyloid-beta as a surrogate endpoint in trials of anti-amyloid-beta drugs in Alzheimer’s disease: a Bayesian meta-analysis”.
🔗 becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #AlzheimersDisease #MetaAnalysis #SurrogateEndpoints
New Research Article on “Evaluating amyloid-beta as a surrogate endpoint in trials of anti-amyloid-beta drugs in Alzheimer’s disease: a Bayesian meta-analysis”.
🔗 becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #AlzheimersDisease #MetaAnalysis #SurrogateEndpoints
Accelerating #JCA readiness with an #AI-enabled framework for early #PICO identification | becarispublishing.com/digital-cont...
Accelerating JCA readiness with an AI-enabled framework for early PICO identification | Becaris Publishing
becarispublishing.com
December 9, 2025 at 8:29 AM
Accelerating #JCA readiness with an #AI-enabled framework for early #PICO identification | becarispublishing.com/digital-cont...
Reposted by The Evidence Base
📢New article alert
New Research Article on “Evaluating the feasibility of a network meta-analysis comparing treatment options in polycythemia vera”
🔗Read here: becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #MetaAnalysis #ITC #RareDiseases
New Research Article on “Evaluating the feasibility of a network meta-analysis comparing treatment options in polycythemia vera”
🔗Read here: becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #MetaAnalysis #ITC #RareDiseases
Evaluating the feasibility of a network meta-analysis comparing treatment options in polycythemia vera
Aim: Polycythemia vera (PV), a rare, chronic myeloproliferative neoplasm, that negatively
impacts patient outcomes, and optimal therapy remains unclear due to a lack of head-to-head
trials. A targeted...
becarispublishing.com
December 8, 2025 at 4:31 PM
📢New article alert
New Research Article on “Evaluating the feasibility of a network meta-analysis comparing treatment options in polycythemia vera”
🔗Read here: becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #MetaAnalysis #ITC #RareDiseases
New Research Article on “Evaluating the feasibility of a network meta-analysis comparing treatment options in polycythemia vera”
🔗Read here: becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #MetaAnalysis #ITC #RareDiseases
How #AI assisted screening can improve efficiency and accuracy in targeted literature reviews | @thermofishersci.bsky.social becarispublishing.com/digital-cont...
How AI-assisted screening can improve efficiency and accuracy in targeted literature reviews | Becaris Publishing
becarispublishing.com
December 8, 2025 at 11:05 AM
How #AI assisted screening can improve efficiency and accuracy in targeted literature reviews | @thermofishersci.bsky.social becarispublishing.com/digital-cont...
Reposted by The Evidence Base
📢New article alert
New Short Report: “Patient characteristics, burden of disease, healthcare resource utilization & costs in acute myeloid leukemia – a retrospective observational study with German claims data”.
🔗Read here: becarispublishing.com/doi/10.57264...
#OpenAccess #RWE #Leukemia #AML
New Short Report: “Patient characteristics, burden of disease, healthcare resource utilization & costs in acute myeloid leukemia – a retrospective observational study with German claims data”.
🔗Read here: becarispublishing.com/doi/10.57264...
#OpenAccess #RWE #Leukemia #AML
Patient characteristics, burden of disease, healthcare resource utilization and costs in acute myeloid leukemia – a retrospective observational study with German claims data
Aim: To assess patient characteristics, burden of disease, healthcare resource utilization
and costs of acute myeloid leukemia (AML) by treatment intensity in German claims
data. Materials & metho...
becarispublishing.com
December 8, 2025 at 10:31 AM
📢New article alert
New Short Report: “Patient characteristics, burden of disease, healthcare resource utilization & costs in acute myeloid leukemia – a retrospective observational study with German claims data”.
🔗Read here: becarispublishing.com/doi/10.57264...
#OpenAccess #RWE #Leukemia #AML
New Short Report: “Patient characteristics, burden of disease, healthcare resource utilization & costs in acute myeloid leukemia – a retrospective observational study with German claims data”.
🔗Read here: becarispublishing.com/doi/10.57264...
#OpenAccess #RWE #Leukemia #AML
From insights to action: how #PatientExperienceData can improve EU regulatory and healthcare decision-making | Becaris Publishing becarispublishing.com/digital-cont...
From insights to action: how patient experience data can improve EU regulatory and healthcare decision-making | Becaris Publishing
becarispublishing.com
December 5, 2025 at 3:49 PM
From insights to action: how #PatientExperienceData can improve EU regulatory and healthcare decision-making | Becaris Publishing becarispublishing.com/digital-cont...
NICE outlines implementation plans for new #Cost-effectiveness thresholds and EQ-5D-5L value set | Becaris Publishing becarispublishing.com/digital-cont...
NICE outlines implementation plans for new cost-effectiveness thresholds and EQ-5D-5L value set | Becaris Publishing
becarispublishing.com
December 5, 2025 at 1:50 PM
NICE outlines implementation plans for new #Cost-effectiveness thresholds and EQ-5D-5L value set | Becaris Publishing becarispublishing.com/digital-cont...
Reposted by The Evidence Base
📢New article alert
New Research Article on “Iron deficiency treatment pathway in Italy: patients’ perceptions of diagnosis and treatment”.
🔗Read here: becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #Anemia #PatientExperience #RWE
New Research Article on “Iron deficiency treatment pathway in Italy: patients’ perceptions of diagnosis and treatment”.
🔗Read here: becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #Anemia #PatientExperience #RWE
Iron deficiency treatment pathway in Italy: patients’ perceptions of diagnosis and treatment
Aim: This 2023 online survey assessed the management of patients with iron deficiency
anemia/iron deficiency without anemia (IDA/IDWA) in Italy. Materials & methods: The study used the patient’s p...
becarispublishing.com
December 5, 2025 at 11:31 AM
📢New article alert
New Research Article on “Iron deficiency treatment pathway in Italy: patients’ perceptions of diagnosis and treatment”.
🔗Read here: becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #Anemia #PatientExperience #RWE
New Research Article on “Iron deficiency treatment pathway in Italy: patients’ perceptions of diagnosis and treatment”.
🔗Read here: becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #Anemia #PatientExperience #RWE
Reposted by The Evidence Base
📢New article alert
New Research Article: "Comparison treatments for basal ganglia hemorrhage: minimally invasive puncture and drainage versus craniotomy versus conservative treatment".
🔗Read here: becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #Stroke #Neurosurgery
New Research Article: "Comparison treatments for basal ganglia hemorrhage: minimally invasive puncture and drainage versus craniotomy versus conservative treatment".
🔗Read here: becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #Stroke #Neurosurgery
Comparison treatments for basal ganglia hemorrhage: minimally invasive puncture and drainage versus craniotomy versus conservative treatment
Aim: The optimal management strategies for spontaneous intracerebral hemorrhage in the
basal ganglia region are still controversial. The purpose of the present study is
to evaluate the clinical benefi...
becarispublishing.com
December 4, 2025 at 3:14 PM
📢New article alert
New Research Article: "Comparison treatments for basal ganglia hemorrhage: minimally invasive puncture and drainage versus craniotomy versus conservative treatment".
🔗Read here: becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #Stroke #Neurosurgery
New Research Article: "Comparison treatments for basal ganglia hemorrhage: minimally invasive puncture and drainage versus craniotomy versus conservative treatment".
🔗Read here: becarispublishing.com/doi/10.57264...
#OpenAccess #JCER #Stroke #Neurosurgery
How #ExternalControls are shaping regulatory evidence: insights from the EMA-HMA workshop | Becaris Publishing becarispublishing.com/digital-cont...
How external controls are shaping regulatory evidence: insights from the EMA-HMA workshop | Becaris Publishing
becarispublishing.com
December 4, 2025 at 12:15 PM
How #ExternalControls are shaping regulatory evidence: insights from the EMA-HMA workshop | Becaris Publishing becarispublishing.com/digital-cont...
What to expect from the #EUHTARegulation in 2026 | Becaris Publishing becarispublishing.com/digital-cont...
What to expect from the EU HTA Regulation in 2026 | Becaris Publishing
becarispublishing.com
December 4, 2025 at 9:42 AM
What to expect from the #EUHTARegulation in 2026 | Becaris Publishing becarispublishing.com/digital-cont...
ISPOR Europe 2025 through a patient engagement lens: insights from a first-time attendee | Becaris Publishing becarispublishing.com/digital-cont...
Becaris Publishing
becarispublishing.com
December 3, 2025 at 11:17 AM
ISPOR Europe 2025 through a patient engagement lens: insights from a first-time attendee | Becaris Publishing becarispublishing.com/digital-cont...
Patti's People - Patti Peeples speaks with Kristi Martin | Becaris Publishing becarispublishing.com/digital-cont...
Patti's People - Patti Peeples speaks with Kristi Martin | Becaris Publishing
becarispublishing.com
December 3, 2025 at 11:01 AM
Patti's People - Patti Peeples speaks with Kristi Martin | Becaris Publishing becarispublishing.com/digital-cont...
Industry news round-up: updates from November 2025 | Becaris Publishing becarispublishing.com/digital-cont...
Industry news round-up: updates from November 2025 | Becaris Publishing
becarispublishing.com
December 2, 2025 at 11:43 AM
Industry news round-up: updates from November 2025 | Becaris Publishing becarispublishing.com/digital-cont...
Preparing effective systematic literature reviews and indirect treatment comparisons for joint clinical assessment (JCA) | @thermofishersci.bsky.social becarispublishing.com/digital-cont...
Preparing effective systematic literature reviews and indirect treatment comparisons for joint clinical assessment (JCA) | Becaris Publishing
becarispublishing.com
December 2, 2025 at 10:26 AM
Preparing effective systematic literature reviews and indirect treatment comparisons for joint clinical assessment (JCA) | @thermofishersci.bsky.social becarispublishing.com/digital-cont...
Overcoming barriers to cell and gene therapy adoption with real-world evidence | @thermofishersci.bsky.social becarispublishing.com/digital-cont...
Overcoming barriers to cell and gene therapy adoption with real-world evidence | Becaris Publishing
becarispublishing.com
December 1, 2025 at 4:48 PM
Overcoming barriers to cell and gene therapy adoption with real-world evidence | @thermofishersci.bsky.social becarispublishing.com/digital-cont...
Rethinking global pricing strategies through the #mostfavorednation lens becarispublishing.com/digital-cont...
Rethinking global pricing strategies through the most-favored nation lens | Becaris Publishing
becarispublishing.com
December 1, 2025 at 11:53 AM
Rethinking global pricing strategies through the #mostfavorednation lens becarispublishing.com/digital-cont...
How #AI-assisted screening can improve efficiency and accuracy in targeted literature reviews | @thermofishersci.bsky.social becarispublishing.com/digital-cont...
How AI-assisted screening can improve efficiency and accuracy in targeted literature reviews | Becaris Publishing
becarispublishing.com
November 30, 2025 at 6:09 PM
How #AI-assisted screening can improve efficiency and accuracy in targeted literature reviews | @thermofishersci.bsky.social becarispublishing.com/digital-cont...
CMS publishes negotiated prices for fifteen major drugs in the second round of #InflationReductionAct negotiations | Becaris Publishing becarispublishing.com/digital-cont...
CMS publishes negotiated prices for fifteen major drugs in the second round of Inflation Reduction Act negotiations | Becaris Publishing
becarispublishing.com
November 26, 2025 at 4:43 PM
CMS publishes negotiated prices for fifteen major drugs in the second round of #InflationReductionAct negotiations | Becaris Publishing becarispublishing.com/digital-cont...